El glaucoma es una enfermedad ocular progresiva que afecta al nervio óptico y puede llevar a la ceguera irreversible si no se trata a tiempo. Se caracteriza por el aumento de la presión intraocular (PIO), lo que genera daño en el nervio óptico. A menudo, se le conoce como …
Glaucoma: La enfermedad silenciosa que amenaza la visión Read More »
Los detectores de consumo de alcohol, también conocidos como alcoholímetros o etilómetros, son dispositivos utilizados para medir la concentración de alcohol en el aliento de una persona. Son ampliamente empleados por las autoridades de tráfico, empresas y particul …
Cómo funcionan los detectores de consumo de alcohol Read More »
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum in the fledgling non-opioid pain space.
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades Read More »
Robert F. Kennedy Jr., nominee for HHS secretary, seemed unfamiliar with the massive insurance program during Thursday’s hearing, mistakenly saying Medicare Part A mainly paid for primary care or physicians.
RFK Jr. fumbles Medicare basics during second confirmation hearing Read More »
Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while responding positively to the announcement that Julie Kim will take the helm of the Japanese giant in 2026.
Takeda Drops Epilepsy Drug, Names New CEO Amid Q3 Earnings Read More »
CAR T–focused biotech Cargo Therapeutics surprised and disappointed analysts when it announced that it would discontinue a mid-stage trial of its lead program, firi-cel.
Cargo Halts CAR T Trial, Lays Off 50% of Workforce in Pipeline Reset Read More »
Over half of U.S. states currently have laws banning or reducing access to gender-affirming care like puberty blockers for minors. Under the new directive, even more providers could stop offering treatments.
Trump seeks to ban federal funding for youth gender-affirming care Read More »
Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.
Sanofi Earnings Driven by Dupixent, New RSV Vaccine as Hunt for Deals Continues Read More »
CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced Getinge off the U.S. market in 2015.
Getinge exits surgical perfusion, creating opportunity for Livanova Read More »
For 2025, Roche will continue a careful approach to high-priced deals, putting science at the center of its business development decisions, executives said Thursday.
